(Q37821961)

English

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

scientific article published on 20 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

1 reference

based on heuristic

inferred from title

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

Simonetta Viviani

3

object named as

Simonetta Viviani

0 references

Stéphane Chauvie

19

0 references

Francesco Di Raimondo

6

0 references

Maria Cantonetti

object named as

Maria Cantonetti

7

0 references

Sally Barrington

object named as

Sally Barrington

16

0 references

author name string

Andrea Gallamini

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Caterina Patti

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Andrea Rossi

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Francesca Fiore

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Caterina Stelitano

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Tatyana Feldman

9

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Paolo Gavarotti

10

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Roberto Sorasio

11

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Antonino Mulè

12

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Monica Leone

13

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Alessandro Rambaldi

14

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Alberto Biggi

15

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Federico Fallanca

17

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Umberto Ficola

18

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Alessandro Massimo Gianni

20

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Gruppo Italiano Terapie Innovative nei Linfomi (GITIL)

21

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

20 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

152

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

551-560

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

The disappearance of prognostic factors in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

PET/CT for therapy response assessment in lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Improving outcome after positive interim PET in advanced Hodgkin's disease: reality vs expectation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

A Coefficient of Agreement for Nominal Scales

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08485.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2010.08485.X

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37821961&oldid=1766998356"